Edition:
United States

Alkermes Plc (ALKS.OQ)

ALKS.OQ on NASDAQ Stock Exchange Global Select Market

41.33USD
4:00pm EDT
Change (% chg)

$-0.99 (-2.34%)
Prev Close
$42.32
Open
$42.13
Day's High
$42.13
Day's Low
$40.51
Volume
327,447
Avg. Vol
261,432
52-wk High
$71.22
52-wk Low
$38.23

Chart for

About

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central... (more)

Overall

Beta: 2.17
Market Cap(Mil.): $7,913.33
Shares Outstanding(Mil.): 153.66
Dividend: --
Yield (%): --

Financials

  ALKS.OQ Industry Sector
P/E (TTM): -- 85.92 33.73
EPS (TTM): -1.28 -- --
ROI: -12.81 0.63 14.31
ROE: -16.00 1.68 16.04

Recro Pharma shares plummet after FDA rejects non-opioid pain shot

Recro Pharma's shares dropped more than 50 percent on Thursday after the U.S. Food and Drug Administration declined to approve the drugmaker's non-opioid shot IV meloxicam, saying the pain-relieving effect did not meet expectations.

May 24 2018

UPDATE 2-Recro Pharma shares plummet after FDA rejects non-opioid pain shot

* FDA says drug's pain-relieving effect did not meet expectations

May 24 2018

BRIEF-Alkermes Q1 GAAP Loss Per Share $0.40

* Q1 REVENUE $225.2 MILLION VERSUS I/B/E/S VIEW $219.3 MILLION

Apr 26 2018

Competitors

Earnings vs. Estimates